John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$272M |
| 2 |
PayPal
PYPL
|
+$237M |
| 3 |
Tesla
TSLA
|
+$223M |
| 4 |
Advanced Micro Devices
AMD
|
+$169M |
| 5 |
Cencora
COR
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$293M |
| 2 |
JPMorgan Chase
JPM
|
+$226M |
| 3 |
GSK
GSK
|
+$219M |
| 4 |
Procter & Gamble
PG
|
+$202M |
| 5 |
Accenture
ACN
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.55% |
| 2 | Healthcare | 16.09% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KZR
2376
DELISTED
Kezar Life Sciences
KZR
| $194K | ﹤0.01% |
2,751
-5,734
| -68% | -$425K |
|
|
BRFS
2377
DELISTED
BRF SA
BRFS
| $192K | ﹤0.01% |
+121,800
| New | +$253K |
|
2378
Tilray
TLRY
$649M
| $192K | ﹤0.01% |
7,150
-31,948
| -82% | -$1.12M |
|
2379
Huadi International Group
HUDI
$13.6M
| $192K | ﹤0.01% |
+37,841
| New | +$739K |
|
2380
Atomera
ATOM
$176M
| $192K | ﹤0.01% |
+30,860
| New | +$253K |
|
2381
Limbach Holdings
LMB
$497M
| $189K | ﹤0.01% |
18,202
-2,400
| -12% | -$22.9K |
|
|
GLDG
2382
GoldMining Inc
GLDG
$253M
| $188K | ﹤0.01% |
+166,705
| New | +$175K |
|
2383
Century Therapeutics
IPSC
$384M
| $184K | ﹤0.01% |
+35,862
| New | +$339K |
|
2384
Lakeland Industries
LAKE
$112M
| $184K | ﹤0.01% |
13,800
-5,800
| -30% | -$73.4K |
|
2385
Alight
ALIT
$397M
| $181K | ﹤0.01% |
+1,085
| New | +$181K |
|
2386
Porch Group
PRCH
$1.94B
| $181K | ﹤0.01% |
+96,107
| New | +$170K |
|
|
PTOC
2387
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
| $181K | ﹤0.01% |
18,000
| – | – |
|
|
PNT
2388
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $179K | ﹤0.01% |
+24,600
| New | +$183K |
|
|
BDN
2389
Brandywine Realty Trust
BDN
$548M
| $179K | ﹤0.01% |
29,100
-27,047
| -48% | -$174K |
|
|
SLI
2390
Standard Lithium
SLI
$600M
| $178K | ﹤0.01% |
+60,386
| New | +$233K |
|
2391
Acadia Pharmaceuticals
ACAD
$5.11B
| $177K | ﹤0.01% |
+11,137
| New | +$174K |
|
2392
Savara
SVRA
$1.14B
| $177K | ﹤0.01% |
114,272
-7,624
| -6% | -$10.5K |
|
2393
Spyre Therapeutics
SYRE
$9.4B
| $177K | ﹤0.01% |
15,746
+11,602
| +280% | +$209K |
|
2394
VirnetX Holding Corp
VHC
$52.1M
| $177K | ﹤0.01% |
6,795
-3,751
| -36% | -$93K |
|
|
VGR
2395
DELISTED
Vector Group Ltd.
VGR
| $176K | ﹤0.01% |
+14,849
| New | +$157K |
|
|
ONCT
2396
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $175K | ﹤0.01% |
8,752
-9,060
| -51% | -$180K |
|
|
UHG
2397
DELISTED
United Homes Group
UHG
| $171K | ﹤0.01% |
17,000
| – | – |
|
|
SUP
2398
DELISTED
Superior Industries International
SUP
| $170K | ﹤0.01% |
40,177
-1,710
| -4% | -$7.26K |
|
2399
Aclaris Therapeutics
ACRS
$929M
| $169K | ﹤0.01% |
+10,700
| New | +$172K |
|
2400
PepGen
PEPG
$221M
| $168K | ﹤0.01% |
+12,596
| New | +$163K |
|
Similar funds
John Overdeck's Q4 2022 Portfolio in Review
As of Q4 2022, John Overdeck held 3,245 positions worth $31.9B, up 8.2% from $29.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
John Overdeck's Q4 2022 filing shows 801 new, 908 increased, 911 reduced and 472 closed positions. Its largest new stake was Yum! Brands: 1,187,068 shares worth $152M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $293M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q4 2022 buy was Yum! Brands: 1,187,068 shares worth $152M.
- John Overdeck added most to Amazon in Q4 2022, an estimated $272M increase.
- John Overdeck's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $293M.
- John Overdeck fully exited JPMorgan Chase in Q4 2022, selling an estimated $226M.
- John Overdeck's ten largest holdings make up 7.9% of its $31.9B portfolio in Q4 2022.
- John Overdeck opened 801 new positions and closed 472 in Q4 2022.
- John Overdeck's portfolio value rose 8.2% quarter-over-quarter to $31.9B.
Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.